Novartis fined $422.5M in marketing, kickback caseTMCnetBy AP , PHILADELPHIA (AP) — Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and ...Here We Go Again: Novartis Fined for Off-Label MarketingSeeking Alphaall 15 news articles » |